Federman & Sherwood Announces That a Securities Class Action Lawsuit Has Been Filed Against Northwest Biotherapeutics Inc.

Thursday, August 16, 2007 General News
Email Print This Page Comment bookmark
Font : A-A+

OKLAHOMA CITY, Aug. 15 On August 13, 2007, a class actionlawsuit was filed in the United States District Court for the Western Districtof Washington against Northwest Biotherapeutics Inc.(OTC Bulletin Board: NWBO). The complaint alleges violations of federalsecurities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of1934 and Rule 10b-5, including allegations of issuing a series of materialmisrepresentations to the market which had the effect of artificiallyinflating the market price. The class period is from July 9, 2007 through July18, 2007.

Plaintiff seeks to recover damages on behalf of the Class. If you are amember of the Class as described above, you may move the Court no later thanFriday, October 12, 2007, to serve as a lead plaintiff for the Class. However,in order to do so, you must meet certain legal requirements pursuant to thePrivate Securities Litigation Reform Act of 1995.

If you wish to discuss this action, participate in this or any otherlawsuit, or have any questions or concerns regarding this notice, orpreservation of your rights, please contact:William B. Federman FEDERMAN & SHERWOOD 10205 North Pennsylvania Avenue Oklahoma City, OK 73120 Email to: wfederman@aol.com - http://www.federmanlaw.com

SOURCE Federman & Sherwood


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor
Advertisement

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook